Daré Bioscience has launched Flora Sync LF5™, a vaginal probiotic capsule designed to restore vaginal microbiome balance and comfort, marking the company's first direct consumer product and revenue stream. The product is available without prescription for $49 per box and targets issues like vaginal dryness, odor, and microbiome disruption. This launch signifies Daré's shift from a development-stage biotech to a revenue-generating women's health company, with further products like a female arousal cream and treatments for HPV and contraception in the pipeline. The company aims to expand its consumer health offerings backed by science and clinical research.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Viasat and BMW Group have successfully demonstrated the first integrated automotive satellite voice call, allowing drivers to make calls directly through the car's infotainment system even in areas without cellular coverage. This advancement, utilizi...
Iran has warned it will retaliate fiercely if the US targets its infrastructure, following President Trump's threat to strike Iranian power plants and bridges next week if negotiations fail. The US recently conducted airstrikes against Iranian milita...
Solana (SOL) maintains its price in the mid-$70 range, supported by several key developments. These include Circle's recent issuance of $500 million in USDC on the Solana network, increasing liquidity and transactional demand. Additionally, instituti...
